CD8+ TEX cells, characterized by unique molecular patterns and transcriptional characteristics, are closely related to the occurrence and progression of HCC, making them promising diagnostic and prognostic biomarkers as well as potential therapeutic targets. Here, CD8A is linked to hepatocellular carcinoma.